Statistics
Total Visits
| Views | |
|---|---|
| SELEKTİF NMDA-GluN2B RESEPTÖR ANTAGONİSTİ İFENPRODİLİN TİP-1 DİYABETLİ FARELERDE ANTİ-DİYABETİK ETKİLERİ | 234 |
Total Visits per Month
| September 2025 | October 2025 | November 2025 | December 2025 | January 2026 | February 2026 | March 2026 | |
|---|---|---|---|---|---|---|---|
| SELEKTİF NMDA-GluN2B RESEPTÖR ANTAGONİSTİ İFENPRODİLİN TİP-1 DİYABETLİ FARELERDE ANTİ-DİYABETİK ETKİLERİ | 6 | 4 | 2 | 3 | 1 | 5 | 0 |
File Downloads
| Views | |
|---|---|
| HASAN ÇİFTÇİ TEZ.docx | 170 |
Top Country Views
| Views | |
|---|---|
| Turkey | 75 |
| United States | 29 |
| Canada | 7 |
| Germany | 7 |
| United Kingdom | 5 |
| Australia | 4 |
| China | 3 |
| EU | 3 |
| Algeria | 1 |
| India | 1 |
Top City Views
| Views | |
|---|---|
| Sakarya | 11 |
| Istanbul | 9 |
| Ottawa | 7 |
| Menlo Park | 6 |
| Mountain View | 5 |
| Ankara | 4 |
| Cambridge | 3 |
| Melbourne | 3 |
| Oakland | 3 |
| Buffalo | 2 |